Genetic susceptibility of lung cancer in Chinese population: An overview of systematic reviews and meta‐analyses

Zhang, Jie; Zhao, Taiqiang; Xu, Chengjie; Huang, Jian; Yu, Hua

doi:10.1111/jebm.12269

Cited by 9 publications

(7 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…of Tuina (published during 2013-2017) was undertaken to assess the methodology and reporting quality based on AMSTAR (A MeaSurement Tool to Assess systematic Reviews) 2 and PRISMA checklists. 20 The results of this study showed that all SRs were rated as very low quality according to AMSTAR 2, while identified several reporting deficiencies in the PRISMA items (e.g., item 5, 6, and 23). Moreover, in our latest survey of 2447 randomized controlled trials (RCTs) of massage (from 1975 to 2020), we found that the average reporting compliance rates of the CONSORT (Consolidated Standards of Reporting Trials),…”

Section: Introductionmentioning

confidence: 77%

STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM): Extending the CONSORT statement

Zhang

Liang

Lau

et al. 2023

J Evidence Based Medicine

View full text Add to dashboard Cite

Objectives Massage is a common therapy of nonpharmacological treatments, particularly in Tuina (Chinese massage) as its most common style, detailed guidance in reporting the intervention is warranted for its evaluation and replication. Based on the CONSORT (Consolidated Standards of Reporting Trials), we aimed to develop an Extension for Tuina/Massage, namely “The STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM).” Methods A group of professional clinicians, trialists, methodologists, developers of reporting guidelines, epidemiologists, statisticians, and editors has developed this STRICTOTM checklist through a standard methodology process recommended by the EQUATOR (Enhancing the QUAlity and Transparency of Health Research) Network, including prospective registration, literature review, draft of the initial items, three rounds of the Delphi survey, consensus meeting, pilot test, and finalization of the guideline. Results A checklist of seven items (namely Tuina/Massage rationale, details of Tuina/Massage, intervention regimen, other components of the intervention, Tuina/Massage provider background, control or comparator interventions, and precaution measures), and 16 subitems were developed. Explanations and examples (E&E) for each item are also provided. Conclusions The working group hopes that the STRICTOTM, in conjunction with both the CONSORT statement and extension for nonpharmacologic treatment, can improve the reporting quality and transparency of Tuina/Massage clinical research.

show abstract

Section: Introductionmentioning

confidence: 77%

STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM): Extending the CONSORT statement

Zhang

Liang

Lau

et al. 2023

J Evidence Based Medicine

View full text Add to dashboard Cite

show abstract

“…According to the different detection objects, there are many detection methods: ARMS, NGS, ddPCR, and FISH are targeted at DNA; RNA was targeted by RNA-Seq and RT-PCR, and IHC for protein. If the amount of tumor tissue is too small or unable to obtain tissue, we can supplement with liquid biopsy through blood, hydrothorax or ascites, pericardial effusion, cerebrospinal fluid and other specimens (Zhang et al, 2017b).…”

Section: Overview Of Detection Methodsmentioning

confidence: 99%

Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing

Dong

Lin

et al. 2019

Front. Pharmacol.

View full text Add to dashboard Cite

The essence of precision medicine is to achieve the goal of “individualized treatment” through genotyping of patients and targeted therapy. At present, the pathogenic genes of non-small cell lung cancer (NSCLC) have been studied most thoroughly and targeted therapy based on genotyping has been the most successful. This paper focuses on the precision treatment of NSCLC based on genotyping, comparing gene detection methods and summarize the latest progress of NSCLC immunotherapy.

show abstract

“…Host genetic may contribute to the development of the diseases [8,9]. The encoding gene of the Mn-SOD enzyme is located on the long arm of chromosome 6q25.2.…”

Section: Introductionmentioning

confidence: 99%

The association of manganese superoxide dismutase gene polymorphism (Rs4880) with diabetic macular edema in a cohort of type 2 diabetic Egyptian patients

Abdou

Mohammed

Fouli

et al. 2021

Egypt J Med Hum Genet

View full text Add to dashboard Cite

Background Diabetic retinopathy (DR) and diabetic macular edema (DME) are the leading causes of blindness in patients with diabetes. Increasing numbers of people with diabetes worldwide suggest that DR and DME will continue to be major contributors to vision loss and associated functional impairment for years to come. Oxidative stress is a key participant in the development and progression of diabetes mellitus (DM) and its complications. Antioxidant status can affect vulnerability to oxidative damage, onset and progression of diabetes, and complications of diabetes. Manganese superoxide dismutase (Mn-SOD) is a key mitochondrial enzyme in cell defense against reactive oxygen species (ROS). DR and progression to DME have been associated with polymorphism in the second exon of the Mn-SOD gene at the 16th amino acid (Ala16Val) in the mitochondrial targeting sequence (MTS) of the protein. The study aimed to investigate the association between Ala16Val Mn-SOD gene polymorphism and the susceptibility to DR and DME in type 2 DM (T2DM). Results In this study, 150 patients with type 2 DM were enrolled: 100 patients with DR with and without diabetic macular edema (DME) and 50 patients with type 2 diabetes with a duration of 10 years without DR. Ala16Val SNP of the Mn-SOD gene (rs4880) was detected by TaqMan real-time PCR. The results showed that the homozygous polymorphic variant VV between the DME group is significantly higher than the non-DME group (P 0.018) among the DR group. Conclusion Mn SOD A16V polymorphism itself may not be associated with DR; meanwhile, it may be implicated in the pathogenesis of DME.

show abstract

Genetic susceptibility of lung cancer in Chinese population: An overview of systematic reviews and meta‐analyses

Abstract: The current study supports the genetic risk factors of lung cancer for Chinese are more likely to be variants from genes that contribute to the etiology of lung cancer.

Cited by 9 publications

References 20 publications

STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM): Extending the CONSORT statement

STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM): Extending the CONSORT statement

Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing

The association of manganese superoxide dismutase gene polymorphism (Rs4880) with diabetic macular edema in a cohort of type 2 diabetic Egyptian patients

Contact Info

Product

Resources

About